Basophil activation test

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Basophil activation test; BAT

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The basophil activation test (BAT) is a method for the diagnosis of allergies of the immediate type (type I) or pseudoallergic reactions. It uses an in vitro method to represent the in vivo reaction to allergen exposure. It is therefore an important allergological diagnostic component in immediate reactions and closes a diagnostic gap in unclear or difficult cases where discrepancies between the patient's medical history and in vivo/vitro diagnostics have arisen or where serological IgE diagnostics are not available (Strohmmeier D et al. 2017). Furthermore, it represents a test alternative for patients in whom skin testing is not possible for various reasons (e.g. high degree of sensitization with the risk of shock fragments during testing). However, the test is not suitable for detecting delayed-type hypersensitivity reactions (type IV reactions).

IndicationThis section has been translated automatically.

Especially in the diagnosis of IgE-mediated immediate type reactions to various allergens including drugs and insect venoms. In the clarification of penicillin allergy, the use of CD63 or CD203c (see CD classification below) and the determination of specific IgE can increase sensitivity. The role of BAT in non-IgE-mediated reactions, e.g. to non-steroidal anti-inflammatory drugs, has not yet been conclusively clarified.

ImplementationThis section has been translated automatically.

For this in-vitro procedure, the basophilic granulocytes are incubated with the relevant allergens (e.g. drugs, insect venom). After allergen stimulation, the basophils are detected by means of an anti-IgE antibody and their degree of activation is determined by the expression of specific surface markers(CD63 or CD203c, see CD classification below) by flow cytometry (see flow cytometry); alternatively, after allergen stimulation, the"leukotriene release" can be measured by ELISA.

Note(s)This section has been translated automatically.

Basophil activation is determined from heparin blood. The test is particularly suitable for the quantification of allergic reactions to food components/contents and drugs for which no RAST diagnosis exists.

LiteratureThis section has been translated automatically.

  1. Strohmeier d et al (2017) Evaluation of the basophil activation test in the diagnosis of food and drug intolerances. Allerg J Int 26: 72-73

Authors

Last updated on: 29.10.2020